Tesamorelin
Explore tesamorelin, including growth-hormone-releasing hormone biology, FDA-approved use, clinical evidence, safety considerations, and prescription pathways.
What Is Tesamorelin?
Tesamorelin is a synthetic analog of growth-hormone-releasing hormone, or GHRH. It stimulates the pituitary gland to release growth hormone, which increases downstream IGF-1.
An FDA-approved tesamorelin product is indicated to reduce excess abdominal fat in adults with HIV and lipodystrophy. It is not indicated for general weight-loss management, and its long-term cardiovascular safety has not been established.
Treatment requires a prescription, condition-specific evaluation, and monitoring. Product labeling includes contraindications and warnings concerning active malignancy, pregnancy, disruption of the hypothalamic-pituitary axis, elevated IGF-1, fluid retention, glucose intolerance or diabetes, and hypersensitivity.
What Has Tesamorelin Been Studied For?
Clinical trials evaluated tesamorelin for reduction of excess visceral abdominal fat in adults with HIV-associated lipodystrophy. Research has also examined metabolic, liver-fat, body-composition, and neurocognitive outcomes in defined populations.
Evidence from those populations should not be generalized to routine obesity treatment, bodybuilding, anti-aging, or performance uses. The approved indication and product labeling define the established clinical pathway.
A prescriber should assess the underlying diagnosis, contraindications, expected benefit, glucose status, IGF-1 monitoring, and ongoing need for treatment.
Tesamorelin: Approved Use & Prescription Status
Tesamorelin is available in an FDA-approved prescription product for reducing excess abdominal fat in adults with HIV and lipodystrophy. It is not indicated for general weight-loss management, and treatment should follow the approved labeling and appropriate clinical monitoring.
A compounded tesamorelin preparation is not FDA-approved and should not be described as generic or identical to the approved product. Compounding may be considered only when current requirements are satisfied and a licensed prescriber identifies a patient-specific medical need that cannot be met by the approved product.
Freedom’s pharmacists can help patients and licensed prescribers distinguish the FDA-approved pathway from individualized formulation questions and verify current prescription options.
Tesamorelin Prescription Pathways
-
FDA-Approved Tesamorelin
Explore Tesamorelin OptionsFDA-approved tesamorelin has a specific indication, formulation, dosing regimen, administration instructions, and safety information. Treatment should follow the approved labeling and prescriber's assessment.
-
Patient-Specific Questions
Talk to a PharmacistFreedom's pharmacists can help patients and licensed prescribers distinguish the approved product pathway from any individualized formulation question and verify current options.
Tesamorelin Frequently Asked Questions
Is tesamorelin FDA approved?
Yes. FDA has approved a tesamorelin product to reduce excess abdominal fat in adults with HIV and lipodystrophy. It is not approved for general weight-loss management.
Can Freedom compound tesamorelin?
Freedom can review current patient-specific questions with licensed prescribers. Any compounded preparation would not be FDA-approved and may be considered only when current requirements are satisfied and the approved product cannot meet an identified patient's medical need.
Does tesamorelin require a prescription?
Freedom carries select commercially manufactured products containing BPC-157. These products are separate from compounded prescriYes. Tesamorelin is a prescription medication and should be used only under the supervision of a licensed healthcare professional.tion medications and are offered according to their individual product labeling.
How does tesamorelin work?
Tesamorelin is a GHRH analog that stimulates pituitary growth-hormone release and increases downstream IGF-1.
What has tesamorelin been studied for?
Human evidence is limited compared with the amount of preclinical research. Experimental findingsClinical trials established reduction of excess visceral abdominal fat in adults with HIV-associated lipodystrophy. Other research populations and outcomes should not be generalized to routine weight loss or wellness use.should not be assumed to demonstrate safety or effectiveness in people.
What are important tesamorelin safety considerations?
Product labeling includes contraindications and warnings involving active malignancy, pregnancy, disruption of the hypothalamic-pituitary axis, elevated IGF-1, fluid retention, glucose intolerance or diabetes, and hypersensitivity.
Does Freedom sell research-use-only tesamorelin?
No. Freedom Compounding Pharmacy serves patients and licensed healthcare providers and does not sell research-use-only peptides.
Questions About Tesamorelin?
Freedom Compounding Pharmacy can help patients and licensed healthcare providers understand tesamorelin's approved use, safety considerations, and current prescription pathways.